NanoViricides Inc (NYSE American:NNVC)

0.7929
Delayed Data
As of Apr 20
 +0.0129 / +1.65%
Today’s Change
0.72
Today|||52-Week Range
1.64
-9.91%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$58.3M

Company Description

NanoViricides, Inc. is a nano-biopharmaceutical company. The company engages in the discovery, development, and commercialization of therapeutics to advance the care of patients suffering from life-threatening viral infections. It intends to manufacture Injectable and Oral FluCide, HIVCide, Nanoviricide Eye Drops, HerpeCide, DengueCide, RabiCide as well as other drugs for pre-clinical animal studies and human clinical studies. The company was founded by Anil R. Diwan on July 25, 2000 and is headquartered in Shelton, CT.

Contact Information

NanoViricides, Inc.
1 Controls Drive
Shelton Connecticut 06484
P:(203) 937-6137
Investor Relations:

Employees

Shareholders

Individual stakeholders9.62%
Other institutional2.86%
Mutual fund holders2.42%

Top Executives

Anil R. DiwanChairman, President & Chief Executive Officer
Meeta R. VyasChief Financial & Accounting Officer
Randall W. BartonChief Scientific Officer
Jayant TatakeVice President-Research & Development